Arcutis Biotherapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
185.46 |
313.10 |
430.81 |
582.78 |
760.40 |
868.99 |
| Przychód Δ r/r |
0.00% |
68.82% |
37.59% |
35.28% |
30.48% |
14.28% |
| Przychód (min) |
181.24 |
290.21 |
410.11 |
581.08 |
714.40 |
816.43 |
| Przychód (max) |
190.80 |
337.42 |
455.39 |
584.47 |
805.28 |
920.28 |
| EBITDA (średnia) |
-20.69 |
-34.93 |
-48.06 |
-65.01 |
-84.83 |
-96.94 |
| EBIT (średnia) |
-21.18 |
-35.76 |
-49.20 |
-66.55 |
-86.84 |
-99.24 |
| EBIT % |
-11.42% |
-11.42% |
-11.42% |
-11.42% |
-11.42% |
-11.42% |
| Zysk netto (średni) |
-156.96 |
-59.00 |
34.27 |
196.64 |
223.47 |
267.62 |
| Zysk netto % |
-84.63% |
-18.85% |
7.95% |
33.74% |
29.39% |
30.80% |
| EPS (średnia) |
-1.32 |
-0.49 |
0.23 |
1.00 |
1.85 |
2.21 |
| Liczba analityków (Przychody) |
6 |
5 |
7 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
5 |
5 |
6 |
6 |
3 |
4 |
| symbol |
ARQT |
ARQT |
ARQT |
ARQT |
ARQT |
ARQT |